The gene encoding the major envelope glycoprotein complex, gp55-116 (gB), of human cytomegalovirus (HCMV) was expressed at high levels in insect cells utilizing a recombinant baculovirus. The mature intracellular form of the insect-derived gp55-116 was a protein of Mr 150K which contained approximately 50K of N-linked oligosaccharides. The oligosaccharide linkages were almost exclusively endoglycosidase Hsensitive. The 150K protein was processed, presumably by proteolytic cleavage, to yield at least one of the previously defined cleavage products of the gp55-116. This processing step was significantly less efficient in insect cells than the analogous step in mammalian cells. Finally, the insect-derived gp55-116 was highly immunogenic in experimental animals and readily recognized by antibodies contained within HCMVimmune human serum, suggesting that this recombinant protein warrants further study as a potential HCMV subunit vaccine candidate.
Introduction
Human cytomegalovirus (HCMV), the largest of the human herpesviruses, is a well recognized pathogen in humans. Immunocompromised allograft recipients suffer severe and sometimes fatal infections with HCMV in the post-transplant period (Ho, 1982) . Recent reports have stressed the importance of HCMV in patients with human immunodeficiency virus infections (Drew & Mintz, 1984) . In addition, HCMV is the most common cause of congenital viral infections with an annual incidence of 1 ~ in the U.S.A. (Alford etal., 1980; Stagno et al., 1983) . Although only 5 to 10~ of congenitally infected infants suffer demonstrable sequelae following this intra-uterine infection, this represents an estimated 2000 damaged infants every year in the U.S.A. (Alford et al., 1980; Stagno et al., 1983) . Protective immune responses against HCMV are as yet undefined; however, numerous immune effector functions have been described following HCMV infection (Betts & Schmidt, 1981; Ho, 1982; Meyers et al., 1980; Quinnan et al., 1982) . Recently investigators have attempted to study the virus-encoded targets of these responses (Borysiewicz et al., 1988; Forman et al., 1985; Liu et al., 1988; Van Der Voort et al., 1989) . Several reports have focused attention on the envelope glycoproteins because of their immunogenicity as well as their surface expression on infectious virions and virus-infected cells (Liu et al., 1988; Van Der Voort et al., 1989) .
The envelope of HCMV contains an undetermined number of distinct proteins, although currently only six glycosylated species have been well described (Britt, 1984; Britt & Auger, 1985; Gretch et al., 1988; Nowak et al., 1984; Pereira et al., 1984; Rasmussen et al., 1984; Stinski, 1976) . The major component of the envelope is a disulphide-linked complex of proteins consisting of a heavily glycosylated protein of Mr I16K and a less heavily glycosylated protein of Mr 55K (Britt, 1984; Britt & Auger, 1986; Britt & Vugler, 1989) . We have termed this the gp55-116 complex (Britt, 1984) , but other nomenclature commonly in use includes gB, gp58 and gCI (Britt & Auger, 1985; Gretch et al., 1988; Nowak et al., 1984) . It is thought to be the HCMV homologue of herpes simplex virus type I glycoprotein B. The primary translation product of the gp55-116 gene is a 100K protein which is cotranslationally glycosylated and modified to an abundant and stable intracellular form of Mr 150K (Britt & Auger, 1986; Britt & Vugler, 1989) . Following a series of oligosaccharide-modifying steps, a fully glycosylated, penultimate polyprotein of Mr 170K is cleaved to yield the two mature proteins with Mr values 116K and 55K (Britt & Vugler, 1989) . Biochemical and immunological analysis of the mature and immature forms of these proteins has been hampered by the inability to conveniently isolate sufficient quantities of the proteins. It has been estimated that gp55-116 represents less than 1 ~ of the mass of the virion. To circumvent this problem, several prokaryotic and eukar-0000-9228 O 1990 SGM yotic recombinant expression systems have been utilized (Britt et al., 1988; Cranage et al., 1986; Spaete et al., 1988) . At this time we are unaware of any report which details the efficient large scale production of this material from a recombinant system.
The use of baculovirus-based expression systems has been shown to be useful in the isolation of large quantities of recombinant proteins (Fraser, 1989) . Many mammalian viral genes have been successfully expressed in baculovirus at surprisingly high levels (Estes et al., 1987; Hu et al., 1987; Inumaru & Roy, 1987; Matsuura et al., 1986; Murphy et al., 1988; Zhang et al., 1988) . Unfortunately, insect cells do not always authentically glycosylate and process the heterologous protein, resulting in aberrant forms with altered immunogenicity. Because this result cannot be predicted in advance, we expressed the HCMV gp55-116 gene in a baculovirus and analysed its processing and immunogenicity. Although the insect cell-derived HCMV gp55-116 was not glycosylated and processed authentically, it retained its immunogenicity. This expression system should prove invaluable for production of therapeutic and diagnostic HCMV reagents.
Methods
Cells and virus. Spodoptera frugiperda cells, clone SF9 (SF), were maintained in Grace's medium supplemented with 10% (v/v) foetal bovine serum, 100 units/ml penicillin and 50 ~tg/ml gentamicin. Wildtype Autographa californica nuclear polyhedrosis virus (AcMNPV) was obtained from Dr Max Summers, Texas A & M University, College Station, Tx., U.S.A. Wild-type viral DNA was purified by the method of . The construction of the recombinant vaccinia virus containing the intact HCMV gp55-116 (VVCMV) has been described previously (Britt et al., 1988) .
Recombinant baculovirus construction. The baculovirus transfer vector pAcYM1 was provided by Dr David Bishop, Oxford University, Oxford, U.K. (Matsuura et al., 1987) . An XmallI fragment of approximately 3.4 kbp containing the intact HCMV gp55-116 gene was released from pCMVS1 (Britt et aL, 1988) , treated with the Klenow fragment of DNA polymerase and BamHI linkers were added. The resulting fragment was then ligated into pUC 19 by standard techniques to yield the plasmid pXC4. After release of the HCMV gp55-116 from pXC4 with BamHI, the 3-4 kbp fragment was isolated by gel electrophoresis and ligated into the unique BamHI site of pAcYMl to yield the plasmid pYMXC4.
Approximately 5 ktg of CsCl-purified pYMXC4 and 1 Ixg of purified AcMNPV viral DNA were transfected in SF cells by previously described procedures . Four days following the transfection, a large number of the SF cells exhibited polyhedra as detected by light microscopy. At this time the supernatant was collected by centrifugation and used to infect approximately forty 30 mm tissue culture dishes containing SF cells as described . Polyhedron-negative plaques were identified and picked using a Pasteur pipette. Initially, screening was carried out using a 96-well microtitre plate seeded with SF cells and infected with individual polyhedron-negative plaques. Individual wells were inoculated with 50 Ixl of medium containing suspected recombinant baculovirus. Following a 5 day incubation period, the plates were fixed in absolute ethanol and recombinant-positive plaques were identified by an immunofluorescence assay using murine monoclonal antibody 7-17 and fluorescein isothiocyanate-conjugated anti-mouse IgG (Britt, 1984) . Plaques expressing gp55-116 were subjected to three cycles of plaque purification prior to use. One plaque-purified virus, Bac 3.1, was selected for further characterization.
Radiolabelling of Bac 3.1 or wild-type-infected SF cells. Cultures of SF9 cells were infected with either Bac 3.1 or wild-type AcMNPV at an m.o.i, of approximately 10 to ensure uniform infection of the monolayer. Approximately 36 h later, the infected cells were washed extensively with TN medium without methionine and pulse-labelled with 50 ~tCi/ml of [3sS]methionine. Pulse-chase analyses were carried out essentially as described (Britt & Auger, 1986 ) with a pulse period of 5 or 10 min followed by removal of the radioactive medium and replacement with Grace's medium. Radiolabelling with [3H]glucosamine or pH]mannose was done 36 h following infection using approximately 50 ~tCi/ml of radioactive sugar in an 8 h pulse labelling.
Inhibition of N-linked glycosylation was accomplished by incubation of infected SF cells in medium containing 1.0 pg/ml of tunicamycin (TM; Boehringer Mannheim) for 90 rain in TN medium without methionine. The medium was replaced with one containing 1.0 ~tg/ml TM and 50 ~tCi/ml of [35S]methionine and labelling was carried out for 4 to 6 h. Radioisotope incorporation was monitored by measurement of trichloroacetic acid-precipitable counts following solubilization of infected cell proteins.
Immunoprecipitation, SDS-PAGE and Western immunoblotting.
Following radiolabelling, individual cultures were rapidly frozen at -70 °C and then thawed. Infected cell proteins were solubilized in RIPA buffer (1.0% Nonidet P40, 1.0% deoxycholate, 0-1% SDS, 0-05 M-Tris-HC1, 0.15 M-NaCI pH 7.4) at 4 °C for 20 min. Immunoprecipitation with murine monoclonal antibodies, collection of immune complexes with Staphylococcus aureus Cowan I strain and analysis by SDS-PAGE in 7-5% acrylamide gels have been previously described (Britt, 1984; Britt & Auger, 1986) . SDS-PAGE and estimation of migration using Mr standards was carried out as described by Britt (1984) .
Western immunoblotting was done as described by Britt & Auger (1986) . Samples for Western immunoblotting were prepared by immediate solubilizaZtion of infected cell pellets in disruption buffer (2 % SDS, 5 % 2-mercaptoethanol, 0-15 M-Tris-HCI pH 8.0) followed by heating to 100 °C for 3 min.
Endoglycosidase treatment. Endoglycosidase H (Endo H, endo-fl-Nacetylglucosaminidase H; Boehringer Mannheim) treatment of immune-precipitated protein was performed as described previously (Britt & Vugler, 1989) .
Neutralization assays. Neutralizing activity was assayed by a rapid (16 h) immunofluorescence assay (Andreoni et al., 1989) . Briefly, 0-2 ml of mouse serum diluted in medium was added to 0-2 ml of titrated virus containing 10% (v/v) guinea-pig complement. Following a 60 min incubation at 37 °C, 0. l ml of the mixture was added to replicate wells of a 96-well microtitre tissue culture plate containing SF cells. After an approximate 2 h adsorption period, the inoculum was removed, the monolayers were washed once with medium, fresh medium was added and the plate was incubated overnight at 37 °C. The following day the medium was removed, the monolayer washed once with phosphatebuffered saline (PBS, pH 7-4) and fixed in absolute ethanol. Following fixation, the monolayers were stained with monoclonal antibody P63-27 (Andreoni et al., 1989) , which is reactive with the major HCMV immediate protein, pp72, and the number of antigen-positive cells was quantified by immunofluorescence. Results are expressed as the mean percentage reduction of fluorescent nuclei (infectivity). The standard error of the mean of this assay is at most 10%, with usual values of 5 %.
R e s u l t s

Expression of HCMV gp56-116 in insect cells
Protein expression of recombinant baculovirus-infected cells was monitored by immunofluorescence using H C M V gp55-116 specific monoclonal antibodies. Cells infected with recombinant virus Bac 3.1, which contained the intact gene encoding H C M V gp55-116, exhibited bright immunofluorescence indicaling expression of this H C M V protein in insect cells (data not shown). We next examined the expression of H C M V gp55-116 in insect cells by subjecting equivalent quantities of [3SS]methionine-radiolabelled infected cell proteins from recombinant virus 3.1-or wild-type AcMNPV-infected cells to SDS-PAGE. Bac 3.1-infected cells contained a protein of estimated Mr 150K which was not seen in wild-type-infected cells (Fig. 1) . The level of expression was significant as it accounted for an estimated 10 % of the infected cells' [35S]methionine. radiolabelled proteins (Fig. 1) . Immunological characterization of the insect cell-derived gp55-116 was carried out by immunoblotting of wild-type-and 3.1-infected cells using HCMV gp55-specific monoclonal antibody 7-17 (Britt & Auger, 1986) . As controls, VVCMV (Britt et al., 1988) or recombinant vaccinia virus-infected ceils expressing the human immunodeficiency virus gag-pol gene products (VVHIV) were included in the experiments. Monoclonal antibody 7-17 recognized a protein of approximate Mr 150K (gpl50) expressed by Bac 3.1 and a more broadly migrating species of Mr 150K to 170K in VVCMV-infected cells (Fig. 2) . Faster migrating species of M r 55K (gp55) and Mr 52K (gp52) were seen in VVCMV-infected and Bac 3.1-infected cells, respectively (Fig. 2) . As previously reported, monoclonal antibody 7-17 recognized a single species of Mr 55K in gradientpurified H C M V virions (Fig. 2) . These results were consistent with earlier studies and indicated that at least two of the four previously defined intracellular forms of the gp55-16 complex were present in Bac 3.1-infected insect cells (Britt & Auger, 1986) . The increased rate of migration of the gp52 in baculovirus-infected cells, as compared to the migration of gp55 in VVCMV-infected cells, suggested that post-translational modifications of this protein may be different in insect cells compared to mammalian cells. Furthermore, the relative amount of gp52 compared to the higher Mr form, gpl50, in Bac 3.1-infected insect cells was much reduced as compared to near equivalent amounts of the two forms seen in VVCMV-infected cells, suggesting that cleavage of the precursor protein was less efficient within insect cells.
Processing of the HCMV gp55-116 (gB) in insect cells
The synthesis of the H C M V gp55-116 in insect cells was studied by pulse--chase analysis followed by immune precipitation and SDS-PAGE. Monoclonal antibody 7-17 precipitated a protein of estimated Mr 150K following a 10 min pulse labelling (Fig. 3) . During the ensuing chase periods there was a slight but perceptible increase in the Mr of this form suggesting some type of posttranslational modification(s) (Fig. 3) . Approximately 80 min into the chase period, the gp52 was detected (Fig.  3 , lane 5) and this species increased in quantity during the next two chase intervals. In addition, 160 min into the chase period a faint but detectable, broadly migrating form of estimated Mr 80K to 100K was also seen (Fig.  3, lane 6 ). This could possibly represent the insect cell form of the second component of the mature complex, gpll6. A prolonged chase period of 18 h revealed the gpl50 form and trace quantities of the gp52 form (Fig. 3,  lane 8) . These results suggested that the approximate Mr 150K protein initially seen was modified, possibly by oligosaccharide trimming, until a slightly faster migrating form, gpl50, was generated. In addition, the previously recognized gp52 was apparently produced by a post-translational event, most likely by proteolytic cleavage of the gpl50. The carbohydrate modification of insect cell-derived gp55-116 was investigated next. The predominant . Endo H sensitivity of HCMV gp55-116 protein synthesized in insect ceils. A pulse-chase analysis of Bac 3.1-infected cells was carried out as described in Fig. 3 , with chase times as follows: lane 1, 0 min; 2, 5min; 3, 10min; 4, 20min; 5, 40min; 6, 80min; 7, 160min; 8, 320 rain; 9, 24 h. Immune-precipitated proteins were treated with 0-005 units of Endo H or left untreated (control) and analysed by SDS-PAGE.
intracellular form, gp150, contained both glucosamine and mannose as evidenced by immunoprecipitation of this form following radiolabelling of infected cell proteins with either [3H]glucosamine or [3H]mannose (Fig. 4) . We failed to detect incorporation of either radiolabelled sugar into the gp52, most likely owing to the low carbohydrate content of this cleavage product and inefficiency of cleavage of the gpl50 in insect cells t Individual mice were given 106 Bac 3.l-infected SF ceils emulsified in complete Freund's adjuvant followed 10 days later with a similar amount of cells emulsified in incomplete Freund's adjuvant. Mice were bled 7 days later and serum was assayed as above. Control mice were immunized with a prokaryotic cell-derived HCMV DNAbinding protein emulsified in complete Freund's adjuvant and assayed as experimental mice (Britt et al., 1988) . (Britt, 1984; Britt & Vugler, 1989) . To determine the extent of glycosylation, Bac 3.1-infected cells were radiolabelled with [35S]methionine in the presence of T M and analysed by S D S -P A G E . A protein of estimated Mr 100K could be seen in cultures incubated in T M and this species was specifically immunoprecipitated with monoclonal antibody 7-17 along with minor, more slowly migrating proteins which were probably products of incomplete inhibition of N-linked glycosylation by TM (Fig. 5) . Thus, the insect cell-derived gpl50 precursor contained some 50K of N-linked sugars, a finding similar to that reported in mammalian cells (Britt & Vugler, 1989) . The structure of the carbohydrate linkages present in gp 150 were next characterized using Endo H. Following a pulse-chase experiment with similar chase intervals as in Fig. 3 , half of the immuneprecipitated sample was treated with Endo H and the other half left untreated. The samples were then analysed by S D S -P A G E . During all chase intervals the gpl50 appeared to be sensitive to Endo H, with the size being reduced to approximately Mr 100K following Endo H treatment (Fig. 6) . Interestingly, at 80 min into the chase period the migration of the Endo H-treated form was retarded slightly as compared to that seen in previous chase intervals (Fig. 6 ). This decreased migration was also seen in the subsequent chase intervals and in the migration of species detected following a 24 h chase (Fig.  6) , suggesting that at these time points some oligosaccharide side-chains were Endo H-resistant. In this experiment, the Endo H sensitivity of the cleavage product gp52 could not be determined as only trace amounts of this protein were present. 6) . Precipitated proteins were analysed by SDS-PAGE as described in Methods.
Immunogenicity of insect cell-derived HCMV p55-116
The immunogenicity of the insect cell-derived gp55-116 was investigated initially in vivo by injecting Bac 3.1-infected cells into mice. After two immunizations all animals developed significant quantities of neutralizing antibodies indicating the immunogenicity of this insect cell-derived protein (Table 1 ). The reactivity of human HCMV-immune serum against the insect cell-derived gp55-116 was next analysed by immune precipitation and SDS-PAGE. Serum from a seronegative individual failed' to precipitate the insect cell-derived gpl50, whereas serum specimens from four seroimmune individuals precipitated the gp150 (Fig. 7) . Thus, insect cellderived gpl50 appeared to be immunogenic in experimental animals and, perhaps more importantly, was readily recognized by antibodies found in individuals with naturally acquired immunity to HCMV.
Discussion
The use of a recombinant baculovirus allowed significant levels of expression of the HCMV gp55-I 16 (gB) gene in insect cells. Although we have not carried out an analytical purification of the insect cell-derived gp55-116, our initial experiments have suggested that nearly 10% of the total [35S]methionine-radiolabelled infected cell protein was gp55-116. This level of expression was significantly higher than we have previously obtained using a recombinant vaccinia virus containing the HCMV gp55-116 gene (Britt et al., 1988 Maturation of the intracellular precursor of gp55-116 within insect cells involved a processing step, possibly trimming of carbohydrate side-chains, which yielded a fully modified form of estimated Mr 150K. In contrast, processing of the gp55-116 intracellular precursor, gpl50, within mammalian cells involved additional carbohydrate modification to yield a final, fully glycosylated form of estimated Mr 170K (Britt & Vugler, 1989) . In both insect cells and mammalian cells, these fully glycosylated forms were then cleaved into the mature smaller Mr polypeptides. In agreement with previous studies, we found that glycosylation of the HCMV gp55-116 within insect cells was not authentic (Hurwitz, 1988; Kuroda et al., 1986 Kuroda et al., , 1987 . Our results suggested that the vast majority of the oligosaccharide side-chains on the gp 150 contained Endo H-sensitive linkages, whereas the majority of oligosaccharides present on the gp 170 found in mammalian cells contained Endo H-resistant, complex sugars (Britt & Vugler, 1989) . The demonstration of a small number of Endo H-resistant linkages on the insect cell-derived gpl50 raised the possibility that previously described glycoprotein processing pathways unique to insect cells were operative (Hsieh & Robbins, 1984) . We could not demonstrate endoglycosidase Dsensitive sugar linkages on either the gpl50 or gp52 expressed in insect cells (data not shown), suggesting that the insect cell analogue of mammalian complex oligosaccharide linkages, mannose3, (N-acetylglucosamine)2, were not present on the HCMV gp55-116 expressed in insect cells (Hsieh & Robbins, 1984) . In addition, preliminary experiments also suggested that only Endo H-sensitive carbohydrate modifications were present on the gp52, providing additional evidence for the presence of only one type of oligosaccharide side-chains on the gp55-116 molecules (data not shown). Conversely, because we have not characterized the second component of the gp55-116 complex, gp116, following expression of the gp55-116 gene in insect cells, we cannot completely rule out the possibility that this form may contain significant quantities of Endo H-resistant sugars. This possibility must be considered in the light of previous studies in HCMV-infected mammalian cells which indicated that 20 to 30 ~ of the mass of this protein consisted of complex oligosaccharides (Britt & Vugler, 1989) . Our results, however, make this possibility unlikely as we could not detect significant quantities of Endo H-resistant oligosaccharides on fully processed gpl50, the penultimate form within insect ceils. Finally, resistance to either Endo H or Endo D might have resulted from aberrant folding of the insect-derived protein, limiting accessibility to the respective enzyme, and not the actual absence of the specific carbohydrate linkage.
Although some controversy exists over the proteolytic processing of mammalian viral polyproteins expressed in insect cells, our results indicated that cleavage of the gp 150 precursor, into one of the smaller forms (gp52) and probably the second (gp116), did occur in insect cells. At this time we cannot determine whether this cleavage occurred in a homologous site as defined previously in the gp55-116 of HCMV strain Towne (Spaete et al, 1988) . Because anti-gp55 antibodies recognized only one lower Mr form, gp52, it seems likely that cleavage of the precursor occurred at a single site, and not randomly along the molecule. The availability of significant quantities of gpl50 and gp52 should allow us to address this question directly in the future. Although we could demonstrate cleavage of the gpl50 precursor, this processing step was much less efficient in insect cells than that observed in mammalian cells. We estimated that the cleavage product, gp52, represented at most 10 of the intracellular gpl50 in insect cells, whereas the vaccinia recombinant virus-derived cleavage product, gp55, represented approximately 50~ of its intracellular precursor (Fig. 2) . The reason for the inefficiency in the cleavage of the precursor protein in insect cells is unknown. Previous studies utilizing recombinant baculovirus-expressed viral glycoproteins have yielded conflicting results. In some cases, endoproteolytic cleavage has been documented, such as in fowl influenza virus haemagglutinin (Kuroda et al., 1986 (Kuroda et al., , 1987 , but not in the human immunodeficiency virus gpl60 (Rusche et al., 1987) or the haemagglutinin of human influenza virus (Possee, 1986) . As yet, there are no explanations for these discrepant findings, although at least one report suggested that many of the proteolytic enzymes responsible for protein maturation in mammalian cells were not present in insect cells (Lebacq-Verheyden et al., 1988 ). An alternative and more simplistic explanation of our results would be that the enzymic activity responsible for cleavage of the precursor was saturable and unable to process efficiently the large amount of protein present. It was also of interest that cleavage of the gp 150 precursor into the smaller Mr form occurred within a similar postlabelling chase interval as that previously shown for cleavage of the gp55-116 precursor, gpl70, in HCMVinfected human fibroblast cells (Britt & Auger, 1986) . This finding suggested the kinetics of intracellular transport were similar in both cell systems. In addition, we have been able to demonstrate the gp55-116 on the surface of infected insect cells by two different techniques (data not shown), providing additional evidence that the intracellular transport of this glycoprotein was similar in both insect and mammalian cells. Thus, it was unlikely that inefficient cleavage of the intracellular precursor was a result of aberrant or delayed intracellular transport.
Authentic processing and glycosylation of the HCMV gp55-116 in insect cells was apparently not required for immunogenicity. Immunization of mice with Bac 3.1-infected SF cells led to the production of high levels of neutralizing antibodies. The level of neutralizing antibodies generated in these mice was comparable to the levels previously reported in mice immunized with a replicating vaccinia :gp55-116 recombinant virus (Britt et al., 1988) . In addition, the baculovirus-derived gp55-116 was readily recognized by human anti-gp55-116 antibodies produced following naturally acquired HCMV. Thus, it appeared the insect cell-derived gp55-116 was antigenically authentic. Because of the high level of expression of this HCMV protein in insect cells and its apparent antigenicity, this recombinant-derived product might be an important component of a future non-replicating vaccine to limit the morbidity of HCMV infections.
